Crossmark

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12872-020-01403-6

Published Online: 2020-03-12

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Zhe

Zhou, Da-Yan

Su, Yong

Si, Liang-Yi

Xu, Qiang
License Information

Text and Data Mining valid from 2020-03-12

Version of Record valid from 2020-03-12
More Information

Article History

Received: 26 November 2019

Accepted: 28 February 2020

First Online: 12 March 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below